Doctor James McMahon

Research Fellow


James is an infectious diseases physician and HIV researcher at The Alfred hospital and Monash Medical Centre in Melbourne. His work focuses on the clinical care of people with HIV and research to improve outcomes for people with HIV.

He received his PhD from Monash University which focused on social and behavioural factors predicting treatment outcomes for people with HIV. Prior to his PhD James completed an infectious diseases fellowship and a Masters of Public Health at Tufts Medical Center in Boston. He also has appointments in the Department of Infectious Diseases at Monash University, at Tufts University in Boston and is a member of the Australian Society for HIV Medicine’s Sub-Committee for Guidance on HIV Management in Australia.

James’ research interests include strategies to monitor the cascade of HIV care, interventions to maximise retention in HIV care and work to maximise the quality of HIV care in Australia.


  • Infectious Diseases Physician, Department of Infectious Diseases Alfred Hospital, Melbourne, Australia
  • Infectious Diseases Physician, Infectious Diseases Unit, Monash Medical Centre, Melbourne, Australia
  • Adjunct Assistant Professor of Medicine, Department of Public Health and Community Medicine, Tufts University School of Medicine, Boston, USA
  • Adjunct Lecturer, Faculty of Medicine Nursing and Health Sciences, Monash University, Melbourne, Australia


  • 2013-present: Member, Sub-Committee for Guidance on HIV Management in Australia, Australian Society for HIV Medicine
  • 2009-present: Consultant – World Health Organization, HIV Drug Resistance Prevention and Treatment Strategy
  • 2007-2010: Clinical and Research Fellow, Department of Infectious Diseases and Geographic Medicine, Tufts University School of Medicine, Boston, USA
  • 2005-2007: Infectious Diseases Fellowship undertaken at the Austin Hospital, Royal Melbourne, and the Victorian Infectious Diseases Reference Laboratory, Victoria, Australia
  • 2000-2004: Internship and Medical Residency at Austin Hospital, Victoria, Australia


  • 2013: PhD, Faculty of Medicine, Monash University, Melbourne, Australia
  • 2010: Master of Public Health, Epidemiology and Operational Research, Tufts University School of Medicine, Boston, USA
  • 2008: Fellow Royal Australian College of Physicians
  • 1999: MBBS, University of Melbourne, Melbourne, Australia


  • 2010-2013: NHMRC Postgraduate Scholarship, Australia
  • 2012: Best Poster, Australian Society for Infectious Diseases Conference
  • 2011: Best poster, Australasian HIV/AIDS Conference
  • 2011: Australasian Society for HIV Medicine Domestic Conference Scholarship
  • 2009: Tufts MPH Global Health International Travel Scholarship, USA
  • 2008: Travel Grant, ICAAC / IDSA Conference Washington DC, USA

Publications (29)

2022 (1)

  • Favipiravir in early symptomatic COVID-19, a randomised placebo-controlled trial.
    McMahon JH, Lau JSY, Coldham A, Roney J, Hagenauer M, Price S, Bryant M, Garlick J, Paterson A, Lee SJ, O'Bryan J, Hearps A, Tachedjian G, Pinskier H, Phillips C, Garrow S, Pinskier N, Melvin R, Blakeway L, Wisniewski JA, Byers S, Badoordeen GZ, Pereira S, Pragastis K, Trubiano JA, Chua KYL, Kainer M, Molton JS, Gardiner BJ, Pierce AB, Cheng A, Rogers BA, Peleg AY
    EClinicalMedicine. 2022 Dec; 54:101703

2021 (3)

2018 (1)

2017 (4)

2016 (2)

2015 (3)

2014 (3)

2013 (3)

2012 (2)

2011 (4)

2008 (1)

2007 (1)

2006 (1)

News Articles (2)

2020 (1)

2015 (1)

Contact Details




  • Public Health